Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switching to Azarga in patients with uncontrolled intraocular pressure
2009-015795-10Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of brinzolamide in ocular hypertension, sponsored by Alcon Inc. Primary endpoint: Change in intraocular pressure from prior Cosopt therapy. Started Oct 2009; status: completed.
02
Drugs
brinzolamide
03
Conditions
ocular hypertension
Beyond the preview
Go deeper on 2009-015795-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015795-10.